Effects of Hexobendine on cerebral blood flow and metabolism in cerebrovascular disease.
D001565:Benzoates / Q000494:pharmacology*; D001794:Blood Pressure; D001921:Brain / Q000378:metabolism*; D002245:Carbon Dioxide; D002560:Cerebrovascular Circulation / Q000187:drug effects*; D002561:Cerebrovascular Disorders / Q000378:metabolism / Q000503:physiopathology*; D005029:Ethylenediamines / Q000494:pharmacology*; D005947:Glucose / Q000378:metabolism; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007773:Lactates / Q000378:metabolism; D010100:Oxygen / Q000097:blood; D010101:Oxygen Consumption; D010313:Partial Pressure; D011773:Pyruvates / Q000378:metabolism; D014665:Vasodilator Agents / Q000494:pharmacology
D001565:Benzoates; D005029:Ethylenediamines; D007773:Lactates; D011773:Pyruvates; D014665:Vasodilator Agents; D002245:Carbon Dioxide; D005947:Glucose; D010100:Oxygen